TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23053658

Group type: EXPERIMENTAL
Intervention: HA‐CMC (sodium hyaluronate‐carboxymethyl cellulose) applied to the surface of the pectoralis major and serratus anterior muscle after total mastectomy (n=50)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control group (n=49) - total mastectomy without HA‐CMC
Number of subjects: 99
Study: 19229988

Group type: EXPERIMENTAL
Intervention: Standard dose budesonide (9 mg/day for 7 weeks followed by 6 mg/day for 3 weeks)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Induction with 12 mg/day for the first month followed by the same regimen as Group 1
Number of subjects: 70
Study: 17698116

Group type: EXPERIMENTAL
Intervention: Preoperative circulating plasminogen activator inhibitor type I
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Addition of plasminogen activator inhibitor type I to preoperative multivariate model
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Addition of plasminogen activator inhibitor type I to postoperative model
Number of subjects: 429
Study: 10928308

Group type: EXPERIMENTAL
Intervention: Tiapride 100-300 mg/day
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Haloperidol 2-6 mg/day
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306
Study: 8677757

Group type: EXPERIMENTAL
Intervention: Effective chemotherapy in ANLL responders
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy in ANLL responders
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: ALL responders
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Nonresponders in ANLL
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Nonresponders in ALL
Number of subjects: 43
Study: 1591097

Group type: EXPERIMENTAL
Intervention: DNA flow cytometry (DNI and SPF)
Number of subjects: 241
Study: 3895775

Group type: EXPERIMENTAL
Intervention: Suture technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anastomosis level
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Suture line leakage at anastomosis
Number of subjects: 60
Study: 31388914

Group type: EXPERIMENTAL
Intervention: HI-FIVES (skills training program for caregivers)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: HI-FIVES
Number of subjects: 241

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 241
Study: 29602597

Group type: EXPERIMENTAL
Intervention: Atypical antipsychotic drugs (monotherapy for 6 weeks)
Number of subjects: 118
Study: 25968451

Group type: EXPERIMENTAL
Intervention: Pregabalin (150 to 300 mg/d)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 25332243

Group type: EXPERIMENTAL
Intervention: High-dose interferon (HDI) for 1 year
Number of subjects: 432

Group type: COMPARATOR
Intervention: Biochemotherapy (dacarbazine, cisplatin, vinblastine, interleukin-2, IFN alfa-2b, and granulocyte colony-stimulating factor every 21 days for three cycles)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Biochemotherapy
Number of subjects: 432
Study: 22335365

Group type: EXPERIMENTAL
Intervention: Screening method using the Prodromal Questionnaire and CAARMS assessment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Referral method to the diagnostic center using CAARMS assessment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening method
Number of subjects: 0
Study: 20598976

Group type: EXPERIMENTAL
Intervention: Preintervention period (2002-2003)
Number of subjects: 125161

Group type: EXPERIMENTAL
Intervention: Postintervention period (2006-2007)
Number of subjects: 125161

Group type: COMPARATOR
Intervention: Men
Number of subjects: 125161

Group type: EXPERIMENTAL
Intervention: Women aged 40 to 60 years
Number of subjects: 125161
Study: 17573295

Group type: EXPERIMENTAL
Intervention: Standard care plus the COPE intervention
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: Standard care plus friendly visits
Number of subjects: 329

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 329
Study: 15968712

Group type: EXPERIMENTAL
Intervention: Flutin capsules (Julphar, UAE)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prozac capsules (Eli Lilly, UK)
Number of subjects: 24
Study: 12110467

Group type: EXPERIMENTAL
Intervention: Low doses of oral amphetamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acute schizophrenic patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chronic schizophrenic patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy volunteers with high schizotypy scores
Number of subjects: 0
Study: 10723224

Group type: EXPERIMENTAL
Intervention: Erythropoietin concentration in patients with infective endocarditis
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (healthy persons)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Comparison of erythropoietin levels
Number of subjects: 12
Study: 8822427

Group type: EXPERIMENTAL
Intervention: 20 mg of prednisolone daily for 2 weeks prior to IVF treatment
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo daily for 2 weeks prior to IVF treatment
Number of subjects: 53
Study: 2200559

Group type: EXPERIMENTAL
Intervention: HAE
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: HAI with 5-fluorouracil and degradable starch microspheres
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 61
Study: 31980514

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31399773

Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis (DBT)
Number of subjects: 29453

Group type: COMPARATOR
Intervention: Standard digital mammography (DM)
Number of subjects: 29453
Study: 28863524

Group type: EXPERIMENTAL
Intervention: Generalized stochastic Redfield equation (GSRE) theory
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing theory based on the extended Solomon equations
Number of subjects: 0
Study: 26041600

Group type: EXPERIMENTAL
Intervention: Patients free from orthodema at discharge (score=0)
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Patients with low-grade orthodema at discharge
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Patients with high-grade orthodema at discharge
Number of subjects: 496

Group type: EXPERIMENTAL
Intervention: Patients without orthodema at discharge
Number of subjects: 496
Study: 22936114

Group type: EXPERIMENTAL
Intervention: 'Almonga'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 'Curruquilla'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bread
Number of subjects: 0
Study: 21810499

Group type: EXPERIMENTAL
Intervention: Prolene Hernia System (PHS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lichtenstein patch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 20189669

Group type: EXPERIMENTAL
Intervention: Bodyfix
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Abdominal Compression Plate (ACP)
Number of subjects: 24
Study: 17660491

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus platinum analog (oxaliplatin or cisplatin)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus platinum analog (oxaliplatin or cisplatin) in patients with PS = 0
Number of subjects: 503

Group type: COMPARATOR
Intervention: Single-agent gemcitabine
Number of subjects: 503
Study: 16311849

Group type: EXPERIMENTAL
Intervention: Proximal gastrectomy with jejunal pouch interposition (PGJP)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Total gastrectomy with Roux‐en‐Y esophagojejunostomy (TGRY)
Number of subjects: 51
Study: 12542874

Group type: EXPERIMENTAL
Intervention: Subarachnoid spinal analgesia with morphine sulfate (Group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No subarachnoid spinal analgesia (Group B)
Number of subjects: 20
Study: 9708543

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation of the motor cortex in patients with migraine with aura during isometric contraction.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation of the visual cortex in patients with migraine with aura.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation of the motor cortex in patients with migraine without aura.
Number of subjects: 85

Group type: COMPARATOR
Intervention: Transcranial magnetic stimulation of the visual cortex in healthy controls.
Number of subjects: 85
Study: 7608408

Group type: EXPERIMENTAL
Intervention: Acoustic analysis of closing sounds of implanted prosthetic heart valves
Number of subjects: 0
Study: 2093696

Group type: EXPERIMENTAL
Intervention: alpha-tocopherol
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: sulphinpyrazone
Number of subjects: 30
Study: 373871

Group type: EXPERIMENTAL
Intervention: ampicillin (12 g/d)
Number of subjects: 43

Group type: COMPARATOR
Intervention: clindamycin (2.4 g/d) plus gentamicin (5.1 mg/kg daily)
Number of subjects: 43
Study: 31482294

Group type: EXPERIMENTAL
Intervention: Degarelix
Number of subjects: 100

Group type: COMPARATOR
Intervention: Leuprolide
Number of subjects: 100
Study: 30972991

Group type: EXPERIMENTAL
Intervention: Partial submergence treatment for 20 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rice cv. TB (tolerant cultivar)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rice cultivars categorized by tolerance
Number of subjects: 80
Study: 28263919

Group type: EXPERIMENTAL
Intervention: Prognostic Index for Intensive Care after Allogeneic Hematopoietic Stem Cell Transplantation (PICAT)
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: PICAT scores of 0 to 2
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: PICAT scores of >2 to 4
Number of subjects: 656

Group type: EXPERIMENTAL
Intervention: PICAT scores of >4
Number of subjects: 656

Group type: COMPARATOR
Intervention: APACHE II
Number of subjects: 656

Group type: COMPARATOR
Intervention: SOFA
Number of subjects: 656
Study: 25795410

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks
Number of subjects: 272

Group type: COMPARATOR
Intervention: Investigator's choice of chemotherapy (ICC)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 272
Study: 23557077

Group type: EXPERIMENTAL
Intervention: Insulin degludec/insulin aspart (IDegAsp)
Number of subjects: 296

Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 296
Study: 21721594

Group type: EXPERIMENTAL
Intervention: Diazepam autoinjector (10 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Diazepam rectal gel (10 mg)
Number of subjects: 48
Study: 19453040

Group type: EXPERIMENTAL
Intervention: Continuous 5-FU infusion (333 mg/m2/day for 7 days starting from the day of surgery) + oral HCFU (300 mg/day for 2 years starting 2 weeks after surgery) in Group B
Number of subjects: 133

Group type: COMPARATOR
Intervention: Oral HCFU (300 mg/day for 2 years starting 2 weeks after surgery) in Group A
Number of subjects: 133
Study: 16426086

Group type: EXPERIMENTAL
Intervention: Journals with impact factors above 4 points
Number of subjects: 132

Group type: COMPARATOR
Intervention: Journals with impact factors below 4 points
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Trials published in journals with high, medium, and low impact factors (Jadad scale)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Trials published in high-impact factor journals (Cochrane Collaboration Handbook quality criterion)
Number of subjects: 132
Study: 15063918

Group type: EXPERIMENTAL
Intervention: Court-ordered disulfiram treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Voluntary disulfiram treatment
Number of subjects: 36
Study: 10902414

Group type: EXPERIMENTAL
Intervention: Upper body space bisection
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lower body space bisection
Number of subjects: 12
Study: 9018023

Group type: EXPERIMENTAL
Intervention: Regular gum containing sugar and aromatic additives
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gum containing 200 mg theanine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gum base (no sugar, no aromatic additives)
Number of subjects: 20
Study: 7688204

Group type: EXPERIMENTAL
Intervention: 0.1% 13-cis-retinoic acid cream
Number of subjects: 10

Group type: COMPARATOR
Intervention: Cream base only (Control)
Number of subjects: 10
Study: 3302865

Group type: EXPERIMENTAL
Intervention: Beta-lactams
Number of subjects: 0

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 0
Study: 29628452

Group type: EXPERIMENTAL
Intervention: Usual care interventions
Number of subjects: 0
Study: 27746523

Group type: COMPARATOR
Intervention: Granisetron 0.05 mg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Palonosetron 1.5 mcg/kg
Number of subjects: 60
Study: 24654464

Group type: EXPERIMENTAL
Intervention: Diphereline (GnRH agonist)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (no GnRH agonist)
Number of subjects: 42
Study: 21497479

Group type: EXPERIMENTAL
Intervention: 6 servings/day of low glycemic index (LGI) foods
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 8 servings/day of low glycemic index (LGI) foods
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Goal commitment
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Efficacy beliefs
Number of subjects: 2
Study: 19740580

Group type: COMPARATOR
Intervention: Classic cinch suture
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Modified cinch suture
Number of subjects: 40
Study: 18671458

Group type: EXPERIMENTAL
Intervention: Apricitabine 1200 mg administered after fasting
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Apricitabine 1200 mg administered after a high-fat meal
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of fasting vs high-fat meal administration
Number of subjects: 20
Study: 15750359

Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 12019669

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10658408

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine 100 mg before surgical incision (group-K1)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Intravenous ketamine after laparotomy (group-K2)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (group-C)
Number of subjects: 39
Study: 7495944

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg b.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg b.d.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg b.d., intravenous drip infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg b.d., bolus injection
Number of subjects: 0
Study: 2207868

Group type: EXPERIMENTAL
Intervention: 1% indomethacin
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: 1% prednisolone acetate
Number of subjects: 46

Group type: COMPARATOR
Intervention: Artificial tears (control group)
Number of subjects: 46
Study: 657166

Group type: EXPERIMENTAL
Intervention: Triazinate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pyrazofurin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 30350398

Group type: EXPERIMENTAL
Intervention: Folic acid + vitamin B12
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Monomeric and oligomeric flavanols (MOF)
Number of subjects: 57
Study: 26658126

Group type: EXPERIMENTAL
Intervention: Weight-based dosing of 0.5 mg kg(‐1) twice daily
Number of subjects: 84

Group type: COMPARATOR
Intervention: Fixed dose of 40 mg daily
Number of subjects: 84
Study: 24517899

Group type: EXPERIMENTAL
Intervention: Routine care with intermittent changes to body and head position, reduced sandbag compression time to 1 hour, and allowed ambulation after 6 hours.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care with 6-24 hours of bed rest in supine position and sandbag compression for 6 hours.
Number of subjects: 80
Study: 22486334

Group type: EXPERIMENTAL
Intervention: Online version of TLFB assessment
Number of subjects: 102

Group type: COMPARATOR
Intervention: In-person interview format
Number of subjects: 102
Study: 20213013

Group type: EXPERIMENTAL
Intervention: Mucoadhesive lipid-based bioerodable tablet
Number of subjects: 20

Group type: COMPARATOR
Intervention: Biotène mouthwash
Number of subjects: 20
Study: 18413214

Group type: EXPERIMENTAL
Intervention: Venlafaxine HCl
Number of subjects: 60

Group type: COMPARATOR
Intervention: Combination of vitamins B(1) and B(6) tablets
Number of subjects: 60
Study: 15814161

Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg, twice daily, for 16 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12219852

Group type: EXPERIMENTAL
Intervention: Resistance treatment to deceptive persuasive messages
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resistance treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Procedure that dispelled participants' illusions of invulnerability
Number of subjects: 0
Study: 10379449

Group type: EXPERIMENTAL
Intervention: Silver-impregnated catheters (Erlanger silver catheters)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control catheters (Quinton Instrument Co.)
Number of subjects: 41
Study: 8966498

Group type: EXPERIMENTAL
Intervention: Intermittent cyclic therapy (ICT) with etidronate
Number of subjects: 88

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 88
Study: 1836677

Group type: EXPERIMENTAL
Intervention: Physician education intervention
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control group (patients seen before the intervention)
Number of subjects: 305
Study: 6670855

Group type: EXPERIMENTAL
Intervention: 5% acyclovir in an aqueous cream base
Number of subjects: 113
Study: 31336366

Group type: EXPERIMENTAL
Intervention: White Light Imaging (WLI)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Linked Color Imaging (LCI)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement for WLI
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Inter-observer agreement for LCI
Number of subjects: 127
Study: 30859993

Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation (TMS) treatment
Number of subjects: 1

Group type: COMPARATOR
Intervention: Maintenance therapy (not performed)
Number of subjects: 1
Study: 28344176

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS) with a margin dose >20 Gy
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS) with a margin dose ≤20 Gy
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 232
Study: 27123421

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose 1 μg/kg over 15 minutes, maintenance 0.5 μg/kg/h)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (loading dose 50 mg/kg over 15 minutes, maintenance 15 mg/kg/h)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 90
Study: 24268564

Group type: EXPERIMENTAL
Intervention: Rothschild Scale for Antidepressant Tachyphylaxis® (RSAT)
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ)
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Sheehan Disability Scale (SDS)
Number of subjects: 483

Group type: EXPERIMENTAL
Intervention: Apathy Evaluation Scale‐Clinician rated version (AES‐C)
Number of subjects: 483
Study: 22615018

Group type: EXPERIMENTAL
Intervention: Balanced propofol sedation (BPS)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Propofol monosedation
Number of subjects: 206
Study: 20299362

Group type: EXPERIMENTAL
Intervention: Extended release niacin combined with laropiprant (ERN-L)
Number of subjects: 1547

Group type: EXPERIMENTAL
Intervention: Extended release niacin alone (ERN)
Number of subjects: 1547

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1547
Study: 18797091

Group type: EXPERIMENTAL
Intervention: ProTaper hand
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ProTaper rotary
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ProFile
Number of subjects: 30
Study: 18161210

Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg/day)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 143
Study: 12452452

Group type: EXPERIMENTAL
Intervention: Doxorubicin at 80 mg/m2 x 3, followed by paclitaxel at 140 mg/m2 over 96 h x 3, then 5‐FU at doses of 1285, 1470, or 1655 mg/m2 by continuous intravenous infusion over 72 h x 3
Number of subjects: 19

Group type: COMPARATOR
Intervention: Dose-dense regimen
Number of subjects: 19
Study: 10088585

Group type: EXPERIMENTAL
Intervention: Electrical acupuncture plus comprehensive rehabilitation (n = 59)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Comprehensive rehabilitation only (n = 59)
Number of subjects: 128
Study: 8747680

Group type: EXPERIMENTAL
Intervention: Meridol(R)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Darjeeling tea (< 0.2 ppm F‐)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (tap water:< 0.2 ppm F‐)
Number of subjects: 30
Study: 1953964

Group type: EXPERIMENTAL
Intervention: Tetrahydroaminoacridine (THA) treatment during inpatient phase
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Long-term outpatient treatment with THA
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 10
Study: 6303106

Group type: COMPARATOR
Intervention: CAV (cyclophosphamide, adriamycin, and vincristine)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: CAV plus VP-16-213
Number of subjects: 102
Study: 31505491

Group type: EXPERIMENTAL
Intervention: Topical cyclosporine A (CsA) administered for 12 months after engraftment
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Topical cyclosporine A (CsA)
Number of subjects: 20
Study: 30246505

Group type: EXPERIMENTAL
Intervention: Oral glucose
Number of subjects: 100

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 100
Study: 28357897

Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT) for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no mindfulness training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 27078993

Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Treadmill exercise
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (conventional drug therapy)
Number of subjects: 58